Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Using presepsin levels to guide antibiotic treatment in thoracic aorta surgery patients

Official title: Changes in Antibacterial Therapy Based on Perioperative Dynamics of Presepsin During Reconstructive Thoracic Aorta Surgery

Run by Petrovsky National Research Centre of Surgery · NCT06336213 · Data updated 2026-11-12

This study is testing if measuring a specific marker in the blood can help doctors give the right antibiotics to patients after thoracic aorta surgery to prevent infections and improve recovery.

More Thoracic Aortic Aneurysm trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment50 (estimated)
SponsorPetrovsky National Research Centre of Surgery
Academic / other
Locations1 site (Moscow, Moscow)
StatusRecruiting
StartedJanuary 23, 2024
Main results expectedDecember 15, 2026
Study endsFebruary 15, 2027
Registry record updatedJanuary 29, 2026
Trial IDNCT06336213 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients diagnosed with thoracic aorta aneurysm or dissection.

Probably not a fit

Patients with hemolysis in their blood samples will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the use of presepsin, a biomarker, to predict and manage postoperative complications in patients undergoing thoracic aorta surgery. By monitoring presepsin levels, the study aims to identify patients at risk for infections and adjust antibiotic therapy accordingly, specifically administering ampicillin/sulbactam if necessary. The research builds on previous findings that link presepsin levels to postoperative outcomes, with the goal of improving patient care and reducing complications. The study will evaluate the effectiveness of this tailored approach in enhancing recovery and minimizing inflammatory issues post-surgery.

Why it matters

Potential benefit: If successful, this approach could significantly reduce postoperative infections and improve recovery outcomes for patients undergoing thoracic aorta surgery.

How similar studies have gone: Previous studies have shown promising results using biomarkers like presepsin to predict complications in cardiac surgery, suggesting this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Thoracic aorta aneurysm/dissection

Exclusion Criteria:

Blood sample hemolysis

Where it's running

  • Petrovsky Research National Centre of Surgery (Petrovsky NRCS)
    Moscow, Moscow, Russia
    Recruiting

Study contacts

  • Principal investigator: Boris Akselrod, Professor — Petrovsky NRCS
  • Study coordinator: Artem Gubko, Ph.D.
  • Email: gubko@artvig.ru
  • Phone: +79684241490

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • GORE MBA Arch Endoprosthesis Early Feasibility Study

    This study tests the safety of the MBA device in people with arch-related thoracic aortic diseases to see if it can be used safely in real-world settings.

    Recruiting at 3 sites W.L.Gore & Associates · Los Angeles, California and 2 other locations · NCT07564375

  • Endovascular treatment for aortic arch pathologies in Spain

    This study is testing if special stent devices can help people aged 18 to 90 with serious aortic arch problems live longer and stay safe.

    Recruiting Vascular Investigation Network Spanish Society for Angiology and Vascular Surgery · Madrid · NCT05309707

  • Effects of Myofascial Release on Heart Patients After Sternotomy

    This study tests whether myofascial release can improve breathing and chest mobility after heart surgery in adults with certain heart diseases.

    Recruiting Kaohsiung Veterans General Hospital. · Kaohsiung City · NCT07649330

  • See if spironolactone can reduce aortic stiffness in adults with thoracic aortic aneurysm

    This study tests whether spironolactone reduces aortic stiffness compared with placebo in adults with degenerative thoracic aortic aneurysms.

    Recruiting Phase 1/2 Mayo Clinic · Rochester, Minnesota · NCT07483177

  • Using AI to measure aortic size from CT scans

    This project will test whether an AI tool called Aorta AIM can automatically measure the aorta on CT scans for adults who have or are being checked for aortic aneurysms.

    Recruiting Aiatella Oy · Chapel Hill, North Carolina and 2 other locations · NCT07438327

  • Measuring the shape and strength of the ascending aorta in patients having heart surgery

    We will test whether direct measurements of the aortic wall's mechanical properties taken during heart surgery can better characterize rupture or dissection risk in people with ascending aortic aneurysm by comparing them to patients undergoing heart transplantation without known aortic disease.

    Recruiting Fondazione IRCCS Policlinico San Matteo di Pavia · Pavia, Lombardy · NCT07422129

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.